Zentiva N.V. - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Zentiva N.V.. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Zentiva N.V.. The Group's principal activities are producing, developing and selling of generic pharmaceuticals, including pharmaceutical chemicals, cosmetics and packaging for pharmaceutical products and special purpose equipment and machines for the pharmaceutical industry. The Group's main operations are based on Czech Republic, Slovak Republic, the Baltic states, Romania, Bulgaria, Moldavia and the Commonwealth of independent states. Some branded pharmaceutical products manufactured by the group include: Helicid, Lozap, Torvacard, Simvacard and Ibalgin. On Mar 5, 2007, the Group signed an agreement to acquire 75% of the issued capital of Eczacibasi Generic Pharmaceuticals, a pharmaceutical company in Turkey.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report